Skip to main content

What the FDA labels say about taking them together

Atovaquone and rifampin

Atovaquone's FDA label of March 20, 2026 names rifampin in its drug interactions section; the rifampin label PlainMeds reads does not name atovaquone. The atovaquone label: “Concomitant administration of rifampin or rifabutin reduces atovaquone concentrations; concomitant use with MEPRON oral suspension is not recommended.”

Check it at the source: the atovaquone FDA label on DailyMed (effective March 20, 2026); the rifampin FDA label on DailyMed (effective February 11, 2026, Lupin Pharmaceuticals, Inc.).

What does the atovaquone label say about rifampin?

Atovaquone label, drug interactions

Concomitant administration of rifampin or rifabutin reduces atovaquone concentrations; concomitant use with MEPRON oral suspension is not recommended.

Source: FDA drug label (MEPRON), GlaxoSmithKline LLC, effective March 20, 2026 (SPL set b426b6bf-f07e-4580-97ae-dfca1ddf5b8f), via openFDA; the full label on DailyMed

What does the rifampin label say about atovaquone?

Rifampin's label (effective February 11, 2026) does not name atovaquone in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (rifampin), Lupin Pharmaceuticals, Inc., effective February 11, 2026 (SPL set b56004f0-f23d-47f6-80c7-39884fccbccc), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Which combination products and biosimilars carry the same label text?

Their labels quote the same sentences for their ingredient; each has its own page with its own label dates.

Both medicines on the record

20Atovaquone generic labelers
13Rifampin generic labelers
AtovaquoneRifampin
Labeled forn/an/a
Boxed warningNoNo
Pharmacy cost (NADAC)$0.767 per mL 750 mg/5 mL suspension$0.679 per capsule 300 mg capsule
Shortage nowNo current entryIn shortage

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?